This grant supports studies & planning for early clinical trials of gene-based therapies for ultra-rare neurological & neuromuscular disorders.
Funding support available to study and prove effectiveness of potential neurotherapeutic agents for neurological disorders towards further development.
Encourages translational activities and small clinical studies for neural devices to address disorders affecting the nervous system; includes prototype development, safety testing, and clinical validation.
Funds clinical trials for new treatments or labeling changes for rare neurodegenerative diseases in adults and children, aiming to increase FDA-approved therapies.
Grant supports developing assays to find new therapies for brain and muscle diseases within IGNITE program; doesn't fund clinical trials.
This grant supports creating and validating animal models and tissue systems mimicking neurological disorders to advance neurotherapeutic discovery.